2-amino-5-phosphonovalerate has been researched along with gastrin-releasing peptide in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kallingal, GJ; Mintz, EM | 2 |
Amaral, OB; Luft, T; Roesler, R; Schwartsmann, G | 1 |
3 other study(ies) available for 2-amino-5-phosphonovalerate and gastrin-releasing peptide
Article | Year |
---|---|
Glutamatergic activity modulates the phase-shifting effects of gastrin-releasing peptide and light.
Topics: 2-Amino-5-phosphonovalerate; Animals; Circadian Rhythm; Cricetinae; Dicarboxylic Acids; Drug Interactions; Excitatory Amino Acid Antagonists; Gastrin-Releasing Peptide; Glutamic Acid; Light; Male; Mesocricetus; Neurotransmitter Uptake Inhibitors; Photic Stimulation; Pyrrolidines; Suprachiasmatic Nucleus; Third Ventricle | 2006 |
Transient disruption of fear-related memory by post-retrieval inactivation of gastrin-releasing peptide or N-methyl-D-aspartate receptors in the hippocampus.
Topics: Analysis of Variance; Animals; Avoidance Learning; Bombesin; Excitatory Amino Acid Antagonists; Fear; Gastrin-Releasing Peptide; Hippocampus; Male; Mental Recall; Peptide Fragments; Rats; Rats, Wistar; Reaction Time; Receptors, N-Methyl-D-Aspartate; Time Factors; Valine | 2008 |
An NMDA antagonist inhibits light but not GRP-induced phase shifts when administered after the phase-shifting stimulus.
Topics: Analysis of Variance; Animals; Behavior, Animal; Circadian Rhythm; Cricetinae; Excitatory Amino Acid Antagonists; Gastrin-Releasing Peptide; Gastrointestinal Agents; Light; Male; Microinjections; Receptors, N-Methyl-D-Aspartate; Suprachiasmatic Nucleus; Time Factors; Valine | 2010 |